KUCHING: Malaysia has the potential to become a world-class hub for clinical research due to its genomic diversity, says Health Minister Khairy Jamaluddin.
He said Malaysia’s multi-ethnic population would benefit clinical trials seeking to understand the effectiveness of a new therapy across a diverse Asian population.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
